TSN-084

DB18306InvestigationalSmall molecule

TSN-084: Overview.

Mechanism: Pharmacologically active on Receptor-type tyrosine-protein kinase FLT3, Hepatocyte growth factor receptor, and High affinity nerve growth factor receptor
Curator reviewed
Formula / weight: C₃₂H₂₆F₂N₆O₄ · 596.595 g/mol (avg)
Also known as: 3-PYRIDINECARBOXAMIDE, N-(3-FLUORO-4-((1-METHYL-6-(1H-PYRAZOL-4-YL)-1H-INDAZOL-5-YL)OXY)PHENYL)-1-(4-FLUOROPHENYL)-1,2-DIHYDRO-6-(1-METHYLETHOXY)-2-OXO- · N-[3-fluoro-4-[[1-methyl-6-(1H-pyrazol-4-yl)-1H-indazol-5-yl]oxy]phenyl]-1-(4-fluorophenyl)-1,2-dihydro-6-(1-methylethoxy)-2-oxo-3-pyridinecarboxamide
Code names: TSN-084

Resolves to

Compound

Structure

InChIKeyXSDZOIYDMHIIAQ-UHFFFAOYSA-NSMILESCC(C)OC1=CC=C(C(=O)NC2=CC=C(OC3=C(C=C4N(C)N=CC4=C3)C3=CNN=C3)C(F)=C2)C(=O)N1C1=CC=C(F)C=C1

Targets

What you can answer from here — as of July 09, 2026

5Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

2Clinical trialsPhase, status and sponsor resolved per trial

10+ReferencesStructured and connected to the statements they support

Which drugs share a target with TSN-084, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.